Latest Share Based Payments News

Page 8 of 9
Matrix Composites & Engineering Ltd posted a 12.1% revenue decline to $74.77 million for FY25, reporting a net loss of $2.2 million as subdued drilling buoyancy markets weighed on results despite strong growth in subsea buoyancy products.
Victor Sage
Victor Sage
27 Aug 2025
Terragen Holdings reported a $3.72 million loss for FY25, impacted by drought and lower revenues, while launching dry probiotic products targeting feedlots and completing a $4.76 million equity raise.
Ada Torres
Ada Torres
27 Aug 2025
Iondrive Ltd reported a 94.7% surge in revenue to $1.71 million for FY2025, driven by R&D tax incentives and other income, yet still recorded a net loss of $4.62 million amid high expenses. The company also expanded its footprint in Europe by acquiring a German entity.
Sophie Babbage
Sophie Babbage
26 Aug 2025
Askari Metals is gearing up for a pivotal shareholder meeting to approve its Ethiopian gold and copper acquisition, while restructuring debt and expanding European investor outreach.
Maxwell Dee
Maxwell Dee
26 Aug 2025
Asset Vision Co Limited reported a 22.9% increase in revenue to $5.03 million for FY2025, alongside a widening net loss of $385,797. The company’s Annual Recurring Revenue surged 28%, supported by new contracts and product innovation.
Sophie Babbage
Sophie Babbage
25 Aug 2025
BrainChip Holdings reports a significant revenue surge and reduced losses in H1 2025, underpinned by new contracts, strategic collaborations, and an expanded funding agreement.
Sophie Babbage
Sophie Babbage
22 Aug 2025
Prescient Therapeutics reported an 11.1% reduction in net loss for FY2025, progressing its lead candidate PTX-100 into Phase 2a trials with FDA Fast Track and Orphan Drug designations, supported by a recent $9.8 million capital raise.
Ada Torres
Ada Torres
20 Aug 2025
Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.
Ada Torres
Ada Torres
5 Aug 2025
Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.
Ada Torres
Ada Torres
5 Aug 2025
Red Mountain Mining has kicked off its 2025 exploration program at the Fry Lake Gold-Copper Project in Ontario, targeting historically rich gold and copper zones with a strategic partnership and potential government funding support.
Maxwell Dee
Maxwell Dee
28 July 2025
Platinum Asset Management reported significant net outflows in June 2025, prompting an increase in its FY26 cost savings target to offset revenue pressures. The firm also outlined ongoing expense reductions and forecast modest investment income for FY25.
Claire Turing
Claire Turing
7 July 2025
PointsBet Holdings Limited has updated its FY25 financial outlook, signalling that both revenue and EBITDA are expected to land at the bottom of previously forecasted ranges.
Victor Sage
Victor Sage
27 June 2025